Paper32201779
Selective Intracellular Delivery of Thiolated Cargo to Tumor and Neovasculature Cells Using Histidine-Rich Peptides as Vectors.
Eksteen JJ and 4 others. ACS Omega, 2020. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Selective Intracellular Delivery of Thiolated Cargo to Tumor and Neovasculature Cells Using Histidine-Rich Peptides as Vectors. Papers, record 32201779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32201779
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Selective Intracellular Delivery of Thiolated Cargo to Tumor and Neovasculature Cells Using Histidine-Rich Peptides as Vectors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21663318 | Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. | Bioconjug Chem | 2011 | https://conductscience.org/library/papers/21663318 | PubMed |
| 2 | 8438901 | Platelet multielemental composition, lability, and subcellular localization. | Am J Hematol | 1993 | https://conductscience.org/library/papers/8438901 | PubMed |
| 3 | 14744774 | A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization. | Cancer Res | 2004 | https://conductscience.org/library/papers/14744774 | PubMed |
| 4 | 20971949 | Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. | Blood | 2011 | https://conductscience.org/library/papers/20971949 | PubMed |
| 5 | 19786305 | Probing the Cu(2+) and Zn(2+) binding affinity of histidine-rich glycoprotein. | J Inorg Biochem | 2009 | https://conductscience.org/library/papers/19786305 | PubMed |
| 6 | 19787821 | The pH sensitivity of histidine-containing lytic peptides. | J Pept Sci | 2009 | https://conductscience.org/library/papers/19787821 | PubMed |
| 7 | 17963208 | Prodrug strategies in anticancer chemotherapy. | ChemMedChem | 2008 | https://conductscience.org/library/papers/17963208 | PubMed |
| 8 | 16489009 | Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein. | Cancer Res | 2006 | https://conductscience.org/library/papers/16489009 | PubMed |
| 9 | 15313924 | Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities. | Cancer Res | 2004 | https://conductscience.org/library/papers/15313924 | PubMed |
| 10 | 16436387 | The anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent manner. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16436387 | PubMed |
| 11 | 12564977 | Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. | Adv Drug Deliv Rev | 2003 | https://conductscience.org/library/papers/12564977 | PubMed |
| 12 | 7225317 | Interactions of the histidine-rich glycoprotein of serum with metals. | Biochemistry | 1981 | https://conductscience.org/library/papers/7225317 | PubMed |
| 13 | 19699713 | Intracellular delivery of bovine lactoferricin's antimicrobial core (RRWQWR) kills T-leukemia cells. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19699713 | PubMed |
| 14 | 9177838 | New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability. | Bioconjug Chem | 1997 | https://conductscience.org/library/papers/9177838 | PubMed |
| 15 | 12212806 | Antimicrobial activity of short arginine- and tryptophan-rich peptides. | J Pept Sci | 2002 | https://conductscience.org/library/papers/12212806 | PubMed |
| 16 | 8640796 | Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. | Cancer Res | 1996 | https://conductscience.org/library/papers/8640796 | PubMed |
| 17 | 16313183 | Biophysical and biological studies of end-group-modified derivatives of Pep-1. | Biochemistry | 2005 | https://conductscience.org/library/papers/16313183 | PubMed |
| 18 | 16769050 | Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions. | Exp Cell Res | 2006 | https://conductscience.org/library/papers/16769050 | PubMed |
| 19 | 19403512 | Cell-surface thiols affect cell entry of disulfide-conjugated peptides. | FASEB J | 2009 | https://conductscience.org/library/papers/19403512 | PubMed |
| 20 | 21264222 | Enhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoprotein. | PLoS One | 2011 | https://conductscience.org/library/papers/21264222 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 34773391 | Thiolated Nanoparticles for Biomedical Applications: Mimicking the Workhorses of Our Body. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/34773391 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTSS | 1520 | PubTator's text mining | https://conductscience.org/library/genes/1520 | NCBI Gene |
| HRG | 3273 | PubTator's text mining | https://conductscience.org/library/genes/3273 | NCBI Gene |
| P4HB | 5034 | PubTator's text mining | https://conductscience.org/library/genes/5034 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32201779
GET https://conductscience.org/api/papers/v1/32201779/references?page=2